Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [17]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 19112-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#19112-1-AP, RRID:AB_2113342
- Product name
- GOLPH3 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated GOLPH3 antibody (Cat. #19112-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references GOLPH3/CKAP4 promotes metastasis and tumorigenicity by enhancing the secretion of exosomal WNT3A in non-small-cell lung cancer.
Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome.
Tankyrase-1-mediated degradation of Golgin45 regulates glycosyltransferase trafficking and protein glycosylation in Rab2-GTP-dependent manner.
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma.
FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer.
STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer.
miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
Re-evaluating the roles of myosin 18Aα and F-actin in determining Golgi morphology.
GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer.
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.
Song JW, Zhu J, Wu XX, Tu T, Huang JQ, Chen GZ, Liang LY, Zhou CH, Xu X, Gong LY
Cell death & disease 2021 Oct 21;12(11):976
Cell death & disease 2021 Oct 21;12(11):976
Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome.
Zhu Z, Zhu Q, Cai D, Chen L, Xie W, Bai Y, Luo K
Oncology reports 2021 Jun;45(6)
Oncology reports 2021 Jun;45(6)
Tankyrase-1-mediated degradation of Golgin45 regulates glycosyltransferase trafficking and protein glycosylation in Rab2-GTP-dependent manner.
Yue X, Tiwari N, Zhu L, Ngo HDT, Lim JM, Gim B, Jing S, Wang Y, Qian Y, Lee I
Communications biology 2021 Dec 7;4(1):1370
Communications biology 2021 Dec 7;4(1):1370
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.
Uzureau S, Lecordier L, Uzureau P, Hennig D, Graversen JH, Homblé F, Mfutu PE, Oliveira Arcolino F, Ramos AR, La Rovere RM, Luyten T, Vermeersch M, Tebabi P, Dieu M, Cuypers B, Deborggraeve S, Rabant M, Legendre C, Moestrup SK, Levtchenko E, Bultynck G, Erneux C, Pérez-Morga D, Pays E
Cell reports 2020 Mar 17;30(11):3821-3836.e13
Cell reports 2020 Mar 17;30(11):3821-3836.e13
A Novel Micropeptide Encoded by Y-Linked LINC00278 Links Cigarette Smoking and AR Signaling in Male Esophageal Squamous Cell Carcinoma.
Wu S, Zhang L, Deng J, Guo B, Li F, Wang Y, Wu R, Zhang S, Lu J, Zhou Y
Cancer research 2020 Jul 1;80(13):2790-2803
Cancer research 2020 Jul 1;80(13):2790-2803
FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer.
Yu LN, Liu Z, Tian Y, Zhao PP, Hua X
Frontiers in oncology 2019;9:1424
Frontiers in oncology 2019;9:1424
STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F, Gao P, Wu W, Wang Z, Yang J, Di J, Jiang B, Su X
Journal of experimental & clinical cancer research : CR 2018 Jul 11;37(1):144
Journal of experimental & clinical cancer research : CR 2018 Jul 11;37(1):144
CENPH Inhibits Rapamycin Sensitivity by Regulating GOLPH3-dependent mTOR Signaling Pathway in Colorectal Cancer.
Wu W, Wu F, Wang Z, Di J, Yang J, Gao P, Jiang B, Su X
Journal of Cancer 2017;8(12):2163-2172
Journal of Cancer 2017;8(12):2163-2172
miR34a/GOLPH3 Axis abrogates Urothelial Bladder Cancer Chemoresistance via Reduced Cancer Stemness.
Zhang Q, Zhuang J, Deng Y, Yang L, Cao W, Chen W, Lin T, Lv X, Yu H, Xue Y, Guo H
Theranostics 2017;7(19):4777-4790
Theranostics 2017;7(19):4777-4790
Re-evaluating the roles of myosin 18Aα and F-actin in determining Golgi morphology.
Bruun K, Beach JR, Heissler SM, Remmert K, Sellers JR, Hammer JA
Cytoskeleton (Hoboken, N.J.) 2017 May;74(5):205-218
Cytoskeleton (Hoboken, N.J.) 2017 May;74(5):205-218
GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
Sun J, Yang X, Zhang R, Liu S, Gan X, Xi X, Zhang Z, Feng Y, Sun Y
Cancer medicine 2017 Apr;6(4):834-844
Cancer medicine 2017 Apr;6(4):834-844
GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.
Zhang Q, Zhuang J, Deng Y, Zhao X, Tang B, Yao D, Zhao W, Chang C, Lu Q, Chen W, Zhang S, Ji C, Cao L, Guo H
Oncotarget 2015 Oct 13;6(31):32177-92
Oncotarget 2015 Oct 13;6(31):32177-92
GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
Zhang Y, Ma M, Han B
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Nov;35(11):10833-9
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Nov;35(11):10833-9
GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Dong B, Ji J, Su X
Journal of translational medicine 2014 Jan 21;12:15
Journal of translational medicine 2014 Jan 21;12:15
GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, Zhang G, Xiao R, Wang X, Liu Q, Long D, Yang J, Xu H, Liu F, Liu M, Xie K, Huang R
British journal of cancer 2014 Apr 29;110(9):2250-60
British journal of cancer 2014 Apr 29;110(9):2250-60
Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer.
Hu BS, Hu H, Zhu CY, Gu YL, Li JP
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Feb;34(1):515-20
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Feb;34(1):515-20
Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.
Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, Fang L, Shen H
Diagnostic pathology 2012 Sep 24;7:127
Diagnostic pathology 2012 Sep 24;7:127
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- HeLa cells were subjected to SDS PAGE followed by western blot with 19112-1-AP(GOLPH3 antibody) at dilution of 1:500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The GOLPH3 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human GOLPH3. This antibody recognizes human,mouse,rat antigen. The GOLPH3 antibody has been validated for the following applications: ELISA, WB, IHC, IF analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 19112-1-AP(GOLPH3 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human placenta using 19112-1-AP(GOLPH3 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue
